Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPSTIM clinical trial. ijtr. 2025;1(Suppl 2). doi:10.63676/mp9mtt23